BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9078691)

  • 1. Effect of different oral anticoagulant intensities on prothrombin fragment 1 + 2 in Thai patients with mechanical heart valve prostheses.
    Tientadakul P; Opartkiattikul N; Sangtawesin W; Sakiyalak P
    J Med Assoc Thai; 1997 Feb; 80(2):81-6. PubMed ID: 9078691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
    Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation.
    Ascani A; Iorio A; Agnelli G
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation activation and reactive fibrinolysis in patients receiving oral anticoagulation after total hip or knee replacement.
    van Wersch JW; de Vries-Hanje JC; Oosterbos C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):605-8. PubMed ID: 7841318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
    Koefoed BG; Feddersen C; Gulløv AL; Petersen P
    Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
    Kyrle PA; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Speiser W; Weltermann A; Kaider A; Pabinger I; Lechner K; Eichinger S
    Thromb Haemost; 1997 Nov; 78(5):1327-31. PubMed ID: 9408013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves].
    Zhuang W; Zhou XM; Hu JG; Li JM; Yu JF; Jiang L; Hu DX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):460-2. PubMed ID: 16134606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurement of prothrombin fragment F1+2 for monitoring the anticoagulant effect of phenprocoumon].
    Bruhn HD; Zurborn KH
    Dtsch Med Wochenschr; 1993 Jul; 118(26):967-70. PubMed ID: 8519230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimum anticoagulation control after bileaflet mechanical valve replacement: a prospective multi-institutional study].
    Kitamura M; Koyanagi H; Kawada S; Hosoda Y; Kurosawa H; Takeuchi Y; Kawase M; Wanibuchi Y
    Kyobu Geka; 1999 Nov; 52(12):1001-4. PubMed ID: 10554485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement.
    Koertke H; Zittermann A; Minami K; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Morshuis M; Koerfer J; Seifert D; Koerfer R
    Ann Thorac Surg; 2005 Jun; 79(6):1909-14; discussion 1914. PubMed ID: 15919283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination.
    Bruhn HD; Conard J; Mannucci M; Monteagudo J; Pelzer H; Reverter JC; Samama M; Tripodi A; Wagner C
    Thromb Haemost; 1992 Oct; 68(4):413-7. PubMed ID: 1448772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment.
    Tripodi A; Cattaneo M; Molteni A; Cesana BM; Mannucci PM
    Thromb Haemost; 1998 Mar; 79(3):571-3. PubMed ID: 9531043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.
    Watzke HH; Forberg E; Svolba G; Jimenez-Boj E; Krinninger B
    Thromb Haemost; 2000 May; 83(5):661-5. PubMed ID: 10823258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses.
    Pengo V; Barbero F; Banzato A; Garelli E; Noventa F; Biasiolo A; Zasso A; Dalla Volta S
    Thromb Haemost; 1997 May; 77(5):839-44. PubMed ID: 9184389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial of different intensities of anticoagulation in patients with prosthetic heart valves.
    Saour JN; Sieck JO; Mamo LA; Gallus AS
    N Engl J Med; 1990 Feb; 322(7):428-32. PubMed ID: 2300106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between total prothrombin, native prothrombin and the International Normalized Ratio (INR).
    Braun PJ; Szewczyk KM
    Thromb Haemost; 1992 Aug; 68(2):160-4. PubMed ID: 1412161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of molecular markers for administration of anticoagulant therapy after heart valve replacement].
    Dahm M; Lotz J; Hafner G; Oelert H; Prellwitz W
    Z Kardiol; 1998; 87 Suppl 4():42-5. PubMed ID: 9857466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between six- and four-week intervals in surveillance of oral anticoagulant treatment.
    Pengo V; Barbero F; Biasiolo A; Pegoraro C; Cucchini U; Iliceto S
    Am J Clin Pathol; 2003 Dec; 120(6):944-7. PubMed ID: 14671984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.